tiprankstipranks

Matthew Gline Insider Profile

4 Followers
Matthew Gline, CEO, Director at Roivant Sciences, holds 17.35M shares in Roivant Sciences (Ticker: ROIV).
tipranks
Matthew Gline

Matthew Gline
Roivant Sciences (ROIV)
CEO, Director

Ranked #88,537 out of 99,635 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-71.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$216M
100.00%
A breakdown of Matthew Gline's holdings

Insider Roles

Roivant Sciences
(ROIV)
CEO, Director
Roles that Matthew Gline holds in companies

Most Profitable Insider Trade

Stock:
Roivant Sciences
(ROIV)
Rating:Informative Sell
Date:Sep 24, 2024 - Today
Return:-7.10%
The most profitable trade made by Matthew Gline

Matthew Gline's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Roivant Sciences
Nov 22, 2024
CEO, Director
Uninformative Sell
125.76K
$216.18M
Success Rate for
ROIV
0 out of 2 profitable transactions on
ROIV
0%
Average Return for
ROIV
Average return per transaction on
ROIV
-71.45%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 31, 2023
Uninformative Buy
$250.01K
-
$10.80
Sep 29, 2023
Uninformative Buy
$234.28K
-
$13.19
Dec 29, 2023
Uninformative Buy
$190.03K
-
$11.58
Apr 02, 2024
Uninformative Buy
$1.84M
-
$10.54
Jul 30, 2024
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Matthew Gline's performance on stock

Matthew Gline insider profile FAQ

What is the percentage of profitable transactions made by Matthew Gline?
The percentage of profitable transactions made by Matthew Gline is 0%.
    What is the average return per transaction made by Matthew Gline?
    The average return per transaction made by Matthew Gline is -71.40%.
      What stocks does Matthew Gline hold?
      Matthew Gline holds: ROIV stocks.
        What was Matthew Gline’s latest transaction?
        Matthew Gline latest transaction was an Uninformative Sell of $125.76K.
          What was Matthew Gline's most profitable transaction?
          Matthew Gline’s most profitable transaction was an Informative Sell of ROIV stock on September 24, 2024. The return on the trade was -7.10%.
            What is Matthew Gline's role in Roivant Sciences?
            Matthew Gline's role in Roivant Sciences is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.